Ipsen Announces FDA's Priority Review of Elafibranor for PBC Treatment, with EMA Also Validating MAA
Dec 7, 2023
Pbc Investment Portfolios
GENFIT Announces Phase III Elafibranor Trial Results for PBC, Showcased at AASLD and Featured in NEJM
Nov 14, 2023